The effect of nebivolol on left ventricular hypertrophy in hypertension

被引：8
作者：
Liu, GS
Wang, LY
Van Nueten, L
Ooms, LA
Van Nueten, L
Borgers, M
Van Nueten, L
Janssen, PA
Van Nueten, L
机构：
[1] Janssen Res Fdn, Life Sci, B-2340 Beerse, Belgium
[2] Chinese PLA Gen Hosp, Dept Cardiol, Beijing, Peoples R China
[3] Chinese PLA Gen Hosp, Dept Echocardiog, Beijing, Peoples R China
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 1999年 / 13卷 / 06期
关键词：
hypertension; left ventricular hypertrophy; nebivolol;
D O I：
10.1023/A:1007840123533
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：549 / 551
页数：3
相关论文
共 10 条
  • [1] ACE inhibitor ramipril is more effective than the beta-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study
    AgabitiRosei, E
    Ambrosioni, E
    DalPalu, C
    Muiesan, ML
    Zanchetti, A
    [J]. JOURNAL OF HYPERTENSION, 1995, 13 (11) : 1325 - 1334
  • [2] COCKCROFT JR, 1995, J PHARMACOL EXP THER, V274, P1067
  • [3] CRUICKSHANK JM, 1992, J HUM HYPERTENS, V6, P85
  • [4] REVERSAL OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS - A METAANALYSIS OF 109 TREATMENT STUDIES
    DAHLOF, B
    PENNERT, K
    HANSSON, L
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (02) : 95 - 110
  • [5] NEBIVOLOL INDUCES ENDOTHELIUM-DEPENDENT RELAXATIONS OF CANINE CORONARY-ARTERIES
    GAO, YS
    NAGAO, T
    BOND, RA
    JANSSENS, WJ
    VANHOUTTE, PM
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (06) : 964 - 969
  • [6] HACHAMOVITCH R, 1988, CURR PROB CARDIOLOGY, V13, P369
  • [7] Transient and sustained impacts of hydroxyl radicals on sarcoplasmic reticulum function: protective effects of nebivolol
    Janssen, PML
    Zeitz, O
    Hasenfuss, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 366 (2-3) : 223 - 232
  • [8] ASSOCIATION OF CHANGE IN LEFT-VENTRICULAR MASS WITH PROGNOSIS DURING LONG-TERM ANTIHYPERTENSIVE TREATMENT
    MUIESAN, ML
    SALVETTI, M
    RIZZONI, D
    CASTELLANO, M
    DONATO, F
    AGABITIROSEI, E
    [J]. JOURNAL OF HYPERTENSION, 1995, 13 (10) : 1091 - 1095
  • [9] Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomised trial
    Van Nueten, L
    Taylor, FR
    Robertson, JIS
    [J]. JOURNAL OF HUMAN HYPERTENSION, 1998, 12 (02) : 135 - 140
  • [10] PHARMACOLOGICAL AND HEMODYNAMIC PROFILE OF NEBIVOLOL, A CHEMICALLY NOVEL, POTENT, AND SELECTIVE BETA-1-ADRENERGIC ANTAGONIST
    VANDEWATER, A
    JANSSENS, W
    VANNEUTEN, J
    XHONNEUX, R
    DECREE, J
    VERHAEGEN, H
    RENEMAN, RS
    JANSSEN, PAJ
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 11 (05) : 552 - 563
1